$113.69
2.782.51%
At Close: -
$113.69
00.00%
After Hours: Jul 5, 4:11 PM EDT
15 minutes delayed
DexCom
DXCMNASDAQ
DexCom (NASDAQ:DXCM) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/25/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.20B | $4.35B | $4.33B | Get Alert |
| 02/08/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.15B | $4.35B | $4.33B | Get Alert |
| 01/08/2024 | DXCM | DexCom | FY | 2024 | — | — | — | $4.15B | $4.35B | $4.32B | Get Alert |
| 01/08/2024 | DXCM | DexCom | FY | 2023 | — | — | — | $3.62B | $3.62B | $3.59B | Get Alert |
| 01/08/2024 | DXCM | DexCom | Q4 | 2023 | — | — | — | $1.03B | — | $1.01B | Get Alert |
| 10/26/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.58B | $3.60B | $3.54B | Get Alert |
| 09/06/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.50B | $3.55B | $3.54B | Get Alert |
| 07/27/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.50B | $3.55B | $3.50B | Get Alert |
| 06/26/2023 | DXCM | DexCom | FY | 2025 | — | — | — | $4.60B | $5.10B | — | Get Alert |
| 04/27/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.40B | $3.52B | $3.47B | Get Alert |
| 02/09/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.35B | $3.49B | $3.47B | Get Alert |
| 01/09/2023 | DXCM | DexCom | FY | 2023 | — | — | — | $3.35B | $3.49B | $3.47B | Get Alert |
| 01/09/2023 | DXCM | DexCom | FY | 2022 | — | — | — | $2.91B | $2.91B | $2.90B | Get Alert |
| 01/09/2023 | DXCM | DexCom | Q4 | 2022 | — | — | — | $815.00M | — | $807.65M | Get Alert |
| 10/27/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.88B | $2.91B | $2.89B | Get Alert |
| 07/28/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.86B | $2.91B | $2.92B | Get Alert |
| 04/28/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.82B | $2.94B | $2.92B | Get Alert |
| 02/10/2022 | DXCM | DexCom | FY | 2022 | — | — | — | $2.82B | $2.94B | $2.96B | Get Alert |
| 01/10/2022 | DXCM | DexCom | Q4 | 2021 | — | — | — | $698.00M | $698.00M | $696.47M | Get Alert |
| 01/10/2022 | DXCM | DexCom | FY | 2021 | — | — | — | $2.45B | $2.45B | $2.45B | Get Alert |
| 10/28/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.42B | $2.45B | $2.40B | Get Alert |
| 07/29/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.35B | $2.40B | $2.34B | Get Alert |
| 04/29/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.26B | $2.36B | $2.32B | Get Alert |
| 02/11/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.21B | $2.31B | $2.33B | Get Alert |
| 01/11/2021 | DXCM | DexCom | Q4 | 2020 | — | — | — | $567.00M | — | $550.73M | Get Alert |
| 01/11/2021 | DXCM | DexCom | FY | 2020 | — | — | — | $1.93B | — | $1.91B | Get Alert |
| 01/11/2021 | DXCM | DexCom | FY | 2021 | — | — | — | $2.21B | $2.31B | $2.33B | Get Alert |
| 10/27/2020 | DXCM | DexCom | FY | 2020 | — | — | — | $1.90B | $1.90B | $1.87B | Get Alert |
| 10/26/2020 | DXCM | DexCom | Q3 | 2020 | — | — | — | $500.90M | $500.90M | $476.75M | Get Alert |
| 07/28/2020 | DXCM | DexCom | FY | 2020 | — | — | — | $1.85B | $1.85B | $1.80B | Get Alert |
| 02/13/2020 | DXCM | DexCom | FY | 2020 | — | — | — | $1.73B | $1.77B | $1.77B | Get Alert |
| 01/13/2020 | DXCM | DexCom | Q4 | 2019 | — | — | — | $457.00M | $457.00M | $431.47M | Get Alert |
| 01/13/2020 | DXCM | DexCom | FY | 2019 | — | — | — | $1.47B | $1.47B | $1.44B | Get Alert |
| 01/13/2020 | DXCM | DexCom | FY | 2020 | — | — | — | $1.73B | $1.77B | $1.75B | Get Alert |
| 11/06/2019 | DXCM | DexCom | FY | 2019 | — | — | — | $1.43B | $1.45B | $1.37B | Get Alert |
FAQ
What is the most recent guidance for DexCom (DXCM)?
There have been no specific sales or earnings guidance reported for DexCom in recent months.
Browse guidance and forecast on all stocks.